Welcome to our dedicated page for Health Catalyst news (Ticker: $HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Health Catalyst's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Health Catalyst's position in the market.
Health Catalyst (Nasdaq: HCAT), a top provider of data and analytics technology in healthcare, announced its participation in key investor conferences. CFO Jason Alger and VP of Investor Relations Jack Knight will represent the company.
They will attend The Stifel Cross Sector Insight Conference in Boston, featuring a fireside chat on June 4, 2024, at 9:45am ET. Additionally, they will present at The Goldman Sachs 45th Annual Global Healthcare Conference in Miami, scheduled for June 12, 2024, at 8:40am ET.
Health Catalyst (Nasdaq: HCAT) has launched Health Catalyst Ignite®, a next-generation data and analytics ecosystem designed for the healthcare sector. The platform integrates advanced technologies, healthcare-specific data models, self-service tools, and industry expertise to address the challenges of data management in healthcare. Ignite offers seamless integration, scalability, and flexibility, reducing costs and improving decision-making. It enables data sharing, centralizes data governance, and democratizes analytics to provide faster insights and enhanced control. The platform supports a range of healthcare use cases, from clinical improvement to operational efficiency, leveraging AI and machine learning for predictive insights.
Health Catalyst, Inc. reported strong financial results for the first quarter of 2024, with total revenue of $74.7 million and Adjusted EBITDA of $3.4 million, beating guidance mid-points. The company remains focused on long-term profitability goals and reaffirmed its full-year guidance for 2024. Key metrics show growth in gross profit and margins, with a 1% increase in total revenue year over year. However, there was a 19% decrease in Adjusted EBITDA compared to the same period last year.